1,081
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Calcium-activated nucleotides 1 (CANT1)-driven nuclear factor-k-gene binding (NF-ĸB) signaling pathway facilitates the lung cancer progression

, , , , &
Pages 3183-3193 | Received 15 Aug 2021, Accepted 02 Nov 2021, Published online: 22 Jan 2022

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
  • Yang D, Liu Y, Bai C, et al. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 2020;468:82–87.
  • Clark SB, Alsubait S. Non small cell lung cancer. Treasure Island (FL): StatPearls; 2020.
  • Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.
  • Duruisseaux M, Esteller M. Lung cancer epigenetics: from knowledge to applications. Semin Cancer Biol. 2018;51:116–128.
  • Kodama K, Takahashi H, Oiji N, et al. CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage. FEBS Open Bio. 2020;10(6):1096–1103.
  • Furuichi T, Dai J, Cho TJ, et al. CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant. J Med Genet. 2011;48(1):32–37.
  • Xing Y, Wen X, Ding X, et al. CANT1 lncRNA triggers efficient therapeutic efficacy by correcting aberrant lncing cascade in malignant uveal melanoma. Mol Ther. 2017;25(5):1209–1221.
  • Liu X, Yang Z, Luo X, et al. Calcium-activated nucleotidase 1 silencing inhibits proliferation, migration, and invasion in human clear cell renal cell carcinoma. J Cell Physiol. 2019;234(12):22635–22647.
  • Yang C, Huang X, Li Y, et al. Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology. Brief Bioinform. 2020;22(3):bbaa164.
  • Fridley BL, Batzler A, Li L, et al. Gene set analysis of purine and pyrimidine antimetabolites cancer therapies. Pharmacogenet Genomics. 2011;21(11):701–712.
  • Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.
  • Chen W, Li Z, Bai L, et al. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci. 2011;16:1172–1185.
  • Yang H, Song Z, Hong D. CRBN knockdown mitigates lipopolysaccharide-induced acute lung injury by suppression of oxidative stress and endoplasmic reticulum (ER) stress associated NF-kappaB signaling. Biomed Pharmacother. 2020;123:109761.
  • Cali T, Fedrizzi L, Ottolini D, et al. Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (downstream regulatory element antagonist modulator), is involved in protein folding and degradation. J Biol Chem. 2012;287(22):18478–18491.
  • Ahmmed B, Khan MN, Nisar MA, et al. Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-kappaB signaling pathway. Int J Oncol. 2019;54(2):431–442.
  • Pezzuto A, D’Ascanio M, Ricci A, et al. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: a review. Thorac Cancer. 2020;11(11):3060–3070.
  • Pezzuto A, Perrone G, Orlando N, et al. A close relationship between HIF-1alpha expression and bone metastases in advanced NSCLC, a retrospective analysis. Oncotarget. 2019;10(66):7071–7079.
  • Rossi E, Aieta M, Tartarone A, et al. A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients. Transl Lung Cancer Res. 2021;10(1):80–92.
  • Qiao G, Wang HB, Duan XN, et al. The effect and mechanism of miR-607/CANT1 axis in lung squamous carcinoma. Anticancer Drugs. 2021;32(7):693–702.
  • Gerhardt J, Steinbrech C, Buchi O, et al. The androgen-regulated Calcium-activated nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro. Am J Pathol. 2011;178(4):1847–1860.
  • Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540–555.
  • Macheret M, Halazonetis TD. DNA replication stress as a hallmark of cancer. Annu Rev Pathol. 2015;10:425–448.
  • Claudio U, Alessandro O, Luca C, et al. Visceral leishmaniasis in a patient with lung tumour: a case report. Trop Doct. 2019;49(2):147–149.
  • Martinez GE, Coursey CA, Dodd L, et al. Simultaneous thigh muscle metastasis from lung cancer and Escherichia coli gas producing myonecrosis. Skeletal Radiol. 2008;37(8):763–766.
  • Paganini C, Monti L, Costantini R, et al. Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification. Matrix Biol. 2019;81:70–90.